Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Lacosamide Tablets

Approval Number

国药准字HJ20191025

CompanyUCB PHARMA SA

Registration Date

October 19, 2023

Previous Approval Numbers

H20191025

Drug Information

Generic Name

拉考沙胺片

Trade Name

维派特

Dosage Form

片剂

Strength

50mg

Drug Type

化学药品

Registration Date

October 19, 2023

Expiry Date

October 18, 2028

Company Information

Applicant Company

Company NameUCB PHARMA SA

Company Address

Allée de la Recherche 60, B-1070 Bruxelles, Belgium

Manufacturing Company

Company NameAesica Pharmaceuticals GmbH

Company Address

Galileistrasse 6, 08056 Zwickau, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

拉考沙胺片 - NMPA 批准文号 | MedPath